Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease

BACKGROUND: In certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative radiation (SABR) compared to patients receiving...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Mehrens, Dirk, Unterrainer, Marcus, Corradini, Stefanie, Niyazi, Maximilian, Manapov, Farkhad, Westphalen, C. Benedikt, Froelich, Matthias F., Wildgruber, Moritz, Seidensticker, Max, Ricke, Jens, Rübenthaler, Johannes, Kunz, Wolfgang G.
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239286/
https://ncbi.nlm.nih.gov/pubmed/34211842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.667993
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares